9th Annual Behavioral Health and Aging Conference:
This conference will focus on recent advances and novel approaches to the treatment of depression in late life. This program is designed for all providers serving the aging population.
Target Audience
Providers working with older adults including physicians, nurses, front-line staff, case managers/service coordinators, therapists and clinicians. Family and caregivers are welcome to attend.
Learning Objectives
- Describe novel interventions for late life depression – including TMS and ketamine/esketamine – and their potential role in late life.
- Discuss the latest data on the safety and efficacy of ECT.
- Discuss the appropriate use of genetic testing
- Describe the benefits of integrated primary and behavioral health care.
Additional Information
Attachment | Size |
---|---|
MD43 - Aging Conference - CME Handout (002) APPROVED.pdf | 267.21 KB |
Schedule
8:00 – 8:45 a.m. Continental Breakfast and Registration
8:45 – 9:00 a.m. Welcome Remarks
LalithKumar K. Solai, MD
9:00 – 11:45 a.m. Tools for Outpatient Management of Late Life Depression
9:00 – 10:00 a.m. Genetic Testing and Complementary Medicine Approaches
Ronald Glick, MD
10:00 – 10:15 a.m. Break
10:15 – 11:15 a.m. Integrating Behavioral Health in Primary Care
Ellen M Whyte, MD
11:15 – 11:45 a.m. Discussion forum - Q&A session: Tools for Outpatient Management of Late Life Depression
Moderators: LalithKumar K. Solai, MD
Discussants: Ronald Glick, MD; Ellen M Whyte, MD
11:45 to 12:30 p.m. Lunch (provided)
12:30 to 4:15 p.m. Cutting Edge Interventions for Late Life Depression
12:30 – 1:30 p.m. Ketamine/Esketamine for Late Life Depression
LalithKumar K. Solai, MD
1:30 – 2:30 p.m. Electroconvulsive Therapy (ECT) Update
Daniel Varon, MD
2:30 – 2:45 p.m. Break (questions collected)
2:45 – 3:45 p.m. Transcranial Magnetic Stimulation Therapy (TMS)
Carmen Andreescu, MD
3:45– 4:15 p.m. Discussion forum - Q&A session: Cutting Edge Interventions for Late Life Depression
Moderators: Ellen M Whyte, MD
Discussants: LalithKumar K. Solai, MD; Daniel Varon, MD;
Carmen Andreescu, MD
4:15 p.m. Adjourn
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 6.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 6.00 Attendance